The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Journal
Overview
publication venue for
-
Reversal of pulmonary hypertension and subsequent repair of atrial septal defect after treatment with continuous intravenous epoprostenol.
2005
-
Primary anti-phospholipid antibody syndrome caused by isolated anti-phosphatidylethanolamine antibodies presenting as cryptogenic fibrosing alveolitis with recurrent pulmonary hemorrhage after single-lung transplantation.
2002
-
A Multi-dimensional Classifier to Support Lung Transplant Referral in Patients with Pulmonary Fibrosis.
2024
-
Sixth monovalent XBB.1.5 vaccine elicits robust immune response against emerging SARS-CoV-2 variants in heart transplant recipients.
2024
-
Acute Right Ventricular Geometric Change Predicts Outcomes in HeartMate 3 Patients.
2023
-
Aortic Root Thrombosis in Patients with HeartMate 3 Left Ventricular Assist Device Support.
2023
-
Early Optical Coherence Tomography Evaluation of Donor-Transmitted Atherosclerosis and Cardiac Allograft Vasculopathy: Insights from a Prospective, Single-Center Study.
2023
-
Pulsatility and flow patterns across macro- and microcirculatory arteries of continuous-flow left ventricular assist device patients.
2023
-
Fifth bivalent omicron BA.4/BA.5 vaccination neutralization of SARS-CoV-2 in heart transplant recipients.
2023
-
Correlation between aortic valve protein levels and vector flow mapping of wall shear stress and oscillatory shear index in patients supported with continuous-flow left ventricular assist devices.
2022
-
Bridging to transplant with HeartMate 3 left ventricular assist devices in the new heart organ allocation system: An individualized approach.
2022
-
Anticoagulation in pulmonary arterial hypertension - association with mortality, healthcare utilization, and quality of life: The Pulmonary Hypertension Association Registry (PHAR).
2022
-
Kinetics of cellular and humoral responses to third BNT162B2 COVID-19 vaccine over six months in heart transplant recipients - implications for the omicron variant.
2022
-
Twenty-four-hour blood pressure and heart rate variability are reduced in patients on left ventricular assist device support.
2022
-
Heart transplantation outcomes in cardiac sarcoidosis..
41.
2021
-
Third dose of the BNT162b2 vaccine in heart transplant recipients: Immunogenicity and clinical experience..
41.
2021
-
Transcriptomic heterogeneity of antibody mediated rejection after heart transplant with or without donor specific antibodies..
40.
2021
-
Cerebral vasoreactivity in HeartMate 3 patients..
40.
2021
-
BNT162b2 vaccination in heart transplant recipients: Clinical experience and antibody response..
40.
2021
-
Impact of lung morphology on clinical outcomes with riociguat in patients with pulmonary hypertension and idiopathic interstitial pneumonia: A post hoc subgroup analysis of the RISE-IIP study..
40.
2021
-
Safety of reduced anti-thrombotic strategy in patients with HeartMate 3 left ventricular assist device..
40.
2021
-
Consequences of functional mitral regurgitation and atrial fibrillation in patients with left ventricular assist devices..
39.
2020
-
Donor thyroid hormone therapy and heart transplantation outcomes: ISHLT transplant registry analysis..
39.
2020
-
Impact of left ventricular assist device implantation on mitral regurgitation: An analysis from the MOMENTUM 3 trial..
39.
2020
-
Gut microbiota, endotoxemia, inflammation, and oxidative stress in patients with heart failure, left ventricular assist device, and transplant..
39.
2020
-
Impact of race on survival in pulmonary arterial hypertension: Results from the REVEAL registry..
39.
2020
-
Association between recipient blood type and heart transplantation outcomes in the United States..
39.
2020
-
T follicular helper and memory cell responses and the mTOR pathway in murine heart transplantation..
39.
2019
-
Prognostic value of vasoactive-inotropic score following continuous flow left ventricular assist device implantation..
38.
2019
-
Prognostic implications of serial outpatient blood pressure measurements in patients with an axial continuous-flow left ventricular assist device..
38.
2018
-
Risk of severe primary graft dysfunction in patients bridged to heart transplantation with continuous-flow left ventricular assist devices..
37.
2018
-
Aortic root thrombosis in patients supported with continuous-flow left ventricular assist devices..
37.
2018
-
Clinical and hemodynamic effects of intra-aortic balloon pump therapy in chronic heart failure patients with cardiogenic shock..
37.
2018
-
Limited usefulness of endoscopic evaluation in patients with continuous-flow left ventricular assist devices and gastrointestinal bleeding..
37.
2017
-
Impact of age, sex, therapeutic intent, race and severity of advanced heart failure on short-term principal outcomes in the MOMENTUM 3 trial..
37.
2017
-
Quality of life and functional capacity outcomes in the MOMENTUM 3 trial at 6 months: A call for new metrics for left ventricular assist device patients..
37.
2017
-
The ratio of circulating regulatory cluster of differentiation 4 T cells to endothelial progenitor cells predicts clinically significant acute rejection after heart transplantation..
37.
2017
-
Prevalence of polyreactive innate clones among graft--infiltrating B cells in human cardiac allograft vasculopathy..
37.
2017
-
Dose-dependent association between amiodarone and severe primary graft dysfunction in orthotopic heart transplantation..
36.
2017
-
Ventricular assist device elicits serum natural IgG that correlates with the development of primary graft dysfunction following heart transplantation..
36.
2017
-
Coculturing with endothelial cells promotes in vitro maturation and electrical coupling of human embryonic stem cell-derived cardiomyocytes..
36.
2017
-
Improved outcomes from extracorporeal membrane oxygenation versus ventricular assist device temporary support of primary graft dysfunction in heart transplant..
36.
2016
-
The role of implantable cardioverter defibrillators in patients bridged to transplantation with a continuous-flow left ventricular assist device: A propensity score matched analysis..
36.
2016
-
Discriminatory performance of positive urine hemoglobin for detection of significant hemolysis in patients with continuous-flow left ventricular assist devices..
36.
2016
-
Macrophage/monocyte-specific deletion of Ras homolog gene family member A (RhoA) downregulates fractalkine receptor and inhibits chronic rejection of mouse cardiac allografts..
36.
2016
-
Predictive value of biomarkers of hepatic fibrosis in adult Fontan patients..
36.
2016
-
Infectious complications after cardiac transplantation in patients bridged with mechanical circulatory support devices versus medical therapy..
35.
2016
-
Outcomes after stroke complicating left ventricular assist device..
35.
2016
-
National trends and outcomes in device-related thromboembolic complications and malfunction among heart transplant candidates supported with continuous-flow left ventricular assist devices in the United States..
35.
2016
-
Association of periarterial neovascularization with progression of cardiac allograft vasculopathy and long-term clinical outcomes in heart transplant recipients..
35.
2016
-
Vascular inflammation and abnormal aortic histomorphometry in patients after pulsatile- and continuous-flow left ventricular assist device placement..
35.
2016
-
Familial dilated cardiomyopathy diagnosis is commonly overlooked at the time of transplant listing..
35.
2015
-
Impact of pre-operative coronary artery disease on cardiovascular events following lung transplantation..
35.
2015
-
Incidence and predictors of myocardial recovery on long-term left ventricular assist device support: Results from the United Network for Organ Sharing database..
34.
2015
-
Continuous-flow left ventricular assist devices and usefulness of a standardized strategy to reduce drive-line infections..
35.
2015
-
Early post-operative ventricular arrhythmias in patients with continuous-flow left ventricular assist devices..
34.
2015
-
Incidence and clinical significance of late right heart failure during continuous-flow left ventricular assist device support..
34.
2015
-
Combination of liver biopsy with MELD-XI scores for post-transplant outcome prediction in patients with advanced heart failure and suspected liver dysfunction..
34.
2014
-
Late right heart failure during support with continuous-flow left ventricular assist devices adversely affects post-transplant outcome..
34.
2014
-
Mechanical circulatory support as a bridge to cardiac retransplantation: a single center experience..
34.
2014
-
Outcome of cardiac transplantation in patients requiring prolonged continuous-flow left ventricular assist device support..
34.
2014
-
Prior hematologic conditions carry a high morbidity and mortality in patients supported with continuous-flow left ventricular assist devices..
33.
2014
-
Neutrophil gelatinase-associated lipocalin and cystatin C for the prediction of clinical events in patients with advanced heart failure and after ventricular assist device placement..
33.
2014
-
Advanced heart failure in patients infected with human immunodeficiency virus: is there equal access to care?.
33.
2014
-
Atrial arrhythmias after lung transplant: underlying mechanisms, risk factors, and prognosis..
33.
2014
-
Pre-operative mortality risk assessment in patients with continuous-flow left ventricular assist devices: application of the HeartMate II risk score..
33.
2014
-
A simplified echocardiographic technique for detecting continuous-flow left ventricular assist device malfunction due to pump thrombosis..
33.
2014
-
Device thrombosis in HeartMate II continuous-flow left ventricular assist devices: a multifactorial phenomenon..
33.
2013
-
Continuous-flow left ventricular assist device exchange: clinical outcomes..
33.
2013
-
Outcome of unplanned right ventricular assist device support for severe right heart failure after implantable left ventricular assist device insertion..
33.
2013
-
Increased right-to-left ventricle diameter ratio is a strong predictor of right ventricular failure after left ventricular assist device..
32.
2013
-
Pre-operative echocardiographic features associated with persistent mitral regurgitation after left ventricular assist device implantation..
32.
2013
-
Antithrombotic strategies in children receiving long-term Berlin Heart EXCOR ventricular assist device therapy..
32.
2013
-
Impact of long term left ventricular assist device therapy on donor allocation in cardiac transplantation..
32.
2013
-
Prevalence and timing of bend relief disconnection in patients supported by the late version HeartMate II left ventricular assist device..
32.
2013
-
Clinical outcome of mechanical circulatory support for refractory cardiogenic shock in the current era..
32.
2013
-
The CentriMag ventricular assist device in acute heart failure refractory to medical management..
31.
2012
-
Usefulness of routine surveillance endomyocardial biopsy 6 months after heart transplantation..
31.
2012
-
Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: Use of the Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring system..
31.
2012
-
Hepatic dysfunction and survival after orthotopic heart transplantation: application of the MELD scoring system for outcome prediction..
31.
2012
-
Bridging cardiogenic shock patients with short-term ventricular support at a community hospital to long-term ventricular support at a tertiary hospital..
31.
2012
-
Markers of extracellular matrix turnover and the development of right ventricular failure after ventricular assist device implantation in patients with advanced heart failure..
31.
2011
-
Relationship of right- and left-sided filling pressures in patients with advanced heart failure: a 14-year multi-institutional analysis..
31.
2011
-
Pre-operative and post-operative risk factors associated with neurologic complications in patients with advanced heart failure supported by a left ventricular assist device..
31.
2011
-
Allochimeric molecules and mechanisms in abrogation of cardiac allograft rejection..
31.
2011
-
Tolerance induction by hematopoietic cell transplantation: combined use of stem cells and progenitor cells..
30.
2011
-
Clinical outcomes for continuous-flow left ventricular assist device patients stratified by pre-operative INTERMACS classification..
30.
2010
-
New-onset graft dysfunction after heart transplantation--incidence and mechanism-related outcomes..
30.
2010
-
Prevalence of de novo aortic insufficiency during long-term support with left ventricular assist devices..
29.
2010
-
Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy..
29.
2010
-
Mediastinal radiation and adverse outcomes after heart transplantation..
29.
2009
-
Higher rate of comorbidities after cardiac retransplantation contributes to decreased survival..
28.
2009
-
Reversal of secondary pulmonary hypertension by axial and pulsatile mechanical circulatory support..
29.
2009
-
Neurocognitive assessments in advanced heart failure patients receiving continuous-flow left ventricular assist devices..
28.
2009
-
Heart transplantation in human immunodeficiency virus-positive patients..
28.
2009
-
Effect of left ventricular assist device infection on post-transplant outcomes..
28.
2009
-
C3d and C4d deposition early after lung transplantation..
27.
2008
-
Increased expression of stem cell factor and its receptor after left ventricular assist device support: a potential novel target for therapeutic interventions in heart failure..
27.
2008
-
Long-term outcomes of cardiac transplantation for peri-partum cardiomyopathy: a multiinstitutional analysis..
26.
2007
-
Decorin-mediated transforming growth factor-beta inhibition ameliorates adverse cardiac remodeling..
26.
2006
-
Effect of clenbuterol on cardiac and skeletal muscle function during left ventricular assist device support..
25.
2006
-
Predictors and outcomes of continuous veno-venous hemodialysis use after implantation of a left ventricular assist device..
25.
2006
-
Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure..
25.
2005
-
Mechanical unloading leads to echocardiographic, electrocardiographic, neurohormonal, and histologic recovery..
25.
2005
-
Reduced myocardial blood flow during left ventricular assist device support: a possible cause of premature bypass graft closure..
24.
2005
-
Effect of diabetes on short- and long-term outcomes after left ventricular assist device implantation..
24.
2005
-
Impact of left ventricular assist device (LVAD)-mediated humoral sensitization on post-transplant outcomes..
24.
2005
-
Biventricular assist device-induced right ventricular reverse structural and functional remodeling..
24.
2005
-
A decade experience of cardiac retransplantation in adult recipients..
24.
2005
-
Myocardial restoration with embryonic stem cell bioartificial tissue transplantation..
24.
2005
-
Cellular and hemodynamics responses of failing myocardium to continuous flow mechanical circulatory support using the DeBakey-Noon left ventricular assist device: a comparative analysis with pulsatile-type devices..
24.
2005
-
Heart transplant and left ventricular assist device costs..
24.
2005
-
Simvastatin decreases myocardial tumor necrosis factor alpha content in heart transplant recipients..
24.
2005
-
Infection in permanent circulatory support: experience from the REMATCH trial..
23.
2004
-
Effects of changes in UNOS policy regarding left ventricular assist devices..
23.
2004
-
Home continuous positive inotropic infusion as a bridge to cardiac transplantation in patients with end-stage heart failure..
23.
2004
-
In vitro characterization of aortic retrograde and antegrade flow from pulsatile and non-pulsatile ventricular assist devices..
23.
2004
-
Evidence of improved right ventricular structure after LVAD support in patients with end-stage cardiomyopathy..
23.
2004
-
Mechanical support for the failing cardiac allograft: a single-center experience..
22.
2003
-
Dobutamine stress echocardiography predicts myocardial improvement in patients supported by left ventricular assist devices (LVADs): hemodynamic and histologic evidence of improvement before LVAD explantation..
22.
2003
-
Coronary risk stratification in patients with end-stage lung disease..
21.
2002
-
Influence of graft ischemic time on outcomes following lung transplantation..
20.
2001
-
Lung and heart-lung transplant practice patterns in pulmonary hypertension centers..
20.
2001
-
Regression of fibrosis and hypertrophy in failing myocardium following mechanical circulatory support..
20.
2001
-
Intravenous immunoglobulin therapy in highly sensitized cardiac allograft recipients facilitates transplantation across donor specific IGG positive cross matches..
20.
2001
-
Older recipient age is associated with reduced alloreactivity and graft rejection after cardiac transplantation..
20.
2001
-
Relationship between coronary function by positron emission tomography and temporal changes in morphology by intravascular ultrasound (IVUS) in transplant recipients..
18.
1999
-
Incidence and outcome of primary Epstein-Barr virus infection and lymphoproliferative disease in pediatric heart transplant recipients..
17.
1998
-
Methotrexate for lung transplant recipients with steroid-resistant acute rejection..
15.
1996
-
Enhanced nitric oxide production induced by the administration of L-arginine does not inhibit arterial neointimal formation after overwhelming alloimmune injury..
15.
1996
-
Cardiac function after orthotopic heart transplantation: response to postural changes, exercise, and beta-adrenergic blockade..
13.
1994
-
What are the implications of cardiac infection with cytomegalovirus before heart transplantation?.
13.
1994
-
Magnetic resonance imaging for assessment of tissue rejection after heterotopic heart transplantation..
12.
1993
-
Coronary angiography after heart transplantation: should perioperative study be the "gold standard"?.
11.
1992
-
The relationship of soluble interleukin-2 receptor levels to allograft arteriopathy after heart transplantation..
11.
1992
-
Canine heart-lung transplantation after twenty-four-hour hypothermic preservation with Belzer-UW solution..
10.
1991
-
Elevated soluble interleukin-2 receptor levels early after heart transplantation and long-term survival and development of coronary arteriopathy..
10.
1991
-
COVID-19 leading to acute encephalopathy in a patient with heart transplant..
39.
2020
-
Non-invasive measurement of peripheral, central and 24-hour blood pressure in patients with continuous-flow left ventricular assist device..
36.
2017
-
From extracorporeal membrane oxygenation to ventricular assist device oxygenation without sternotomy..
32.
2013
-
Survival after lung transplant for coal workers' pneumoconiosis..
31.
2012
-
Heart transplant recipient completes ironman triathlon 22 years after surgery..
28.
2009
-
Successful management of asystole with an isolated left ventricular assist device..
25.
2006
-
Heart transplantation of Middle Eastern patients in the United States: A brief report from the UNOS database.
2015
-
Repetitive HeartMate II pump stoppage induced by transitioning from battery to main power source: the short-to-shield phenomenon.
2014
-
Myocardial infarction after left ventricular assist device implantation: clinical course, role of aortic root thrombus, and outcomes.
2013
-
Development of a murine ventricular assist device transcutaneous drive-line model.
2008
-
A mouse aortic patch model for mechanical circulatory support.
2005
-
Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection.
2007
-
ISHLT consensus statement: Perioperative management of patients with pulmonary hypertension and right heart failure undergoing surgery..
41.
2022
-
International guidelines for the selection of lung transplant candidates: 2006 update--a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation.
2006
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)